Alabama Medicaid and GLP-1s
The takeaway
Alabama added Wegovy to its preferred drug list in July 2026 with a footnote saying it isn't covered for weight loss; Zepbound is covered for sleep apnea.
Reading the state documents
Alabama's drug list carries both weight-management GLP-1s and a footnote under each that takes the weight indication back. Zepbound is preferred for obstructive sleep apnea with obesity and non-covered for weight reduction without it. Wegovy is available by authorization for cardiovascular risk and liver disease, and non-covered for weight reduction. The criteria document behind the footnotes requires no diagnosis of diabetes on any of these routes.
What changed, and what the document says
Zepbound is preferred, for one diagnosis
Conditions applyThe footnote scopes the preferred status to a single indication rather than to the drug.
“Zepbound is preferred with clinical criteria for”
Alabama Medicaid Agency — Effective 07/01/2026
And non-covered without it
Not coveredThe second half of the same footnote is the refusal, in the list's own words.
“Zepbound is non-covered for weight”
Alabama Medicaid Agency — Effective 07/01/2026
Wegovy carries the same sentence
Not coveredAlabama added Wegovy to the list effective July 2026 and excluded the weight indication in the same act.
“Wegovy is non-covered for weight reduction.”
Alabama Medicaid Agency — Effective 07/01/2026
No diabetes diagnosis on these routes
Conditions applyThe criteria put the sleep-apnea threshold and the age floor in one sentence, and close it by excluding diabetes.
“moderate to severe obstructive sleep apnea (apnea-hypopnea index [AHI] ≥15)”
Alabama Medicaid Agency, Division of Pharmacy Services — Effective 07/01/2026
Counseling, and no stacking
Conditions applyBoth conditions are in one attestation, so a prescriber confirms them together.
“The patient has been counseled to continue a reduced-calorie diet and increased physical activity”
Alabama Medicaid Agency, Division of Pharmacy Services — Effective 07/01/2026
The liver route needs documentation of the indication
Conditions applyAlabama's MASH pathway is conditioned on evidence for the labeled indication and, again, on not having diabetes.
“with no diagnosis of diabetes.”
Alabama Medicaid Agency, Division of Pharmacy Services — Effective 07/01/2026
Telehealth in Alabama
- Gala HealthPartnerCCaveatSee Gala Health pricing (opens in a new tab)$1,299a month, medication onlybrand Ozempic (semaglutide), cash priceAdditional fees not verified.
Price details
- No separate monthly fee was found in the pages reviewed. Other charges may apply.
- Brand-name Ozempic, quoted as a cash price. Gala says insurance may reduce it and does not publish what it would reduce it to.
Some providers pay us a commission when you sign up through our links, at no extra cost to you.
Which of these companies serve Alabama?
Of the 387 companies we grade, 34 publish a list of the states they are licensed in. We checked 251 more and found no such list on any page we read; 102 we have not checked either way.
12 of those lists name Alabama: Gala Health, Care Bare Rx, TelePeptide, Ways2Well, TeleClinic, Tyde Wellness, Trimi, Rx.com, Mojoon, Peak Wellness, Allara Health, and Mixx Health & Wellness. That is a licensure claim each company makes about itself, not something we checked with a state board.
A published list is a starting point, not a guarantee. If availability decides your choice, ask before you pay and get the answer in writing.
Coverage decides what you pay before cash does. See how state Medicaid programs cover GLP-1s and what a prior-authorization denial turns on.
Sources
Source dates below are the dates printed on the documents.
- Alabama Medicaid Agency Preferred Drug List (PDL) Reference Tool — Alabama Medicaid Agency. Printed in the footer of every page: Effective 07/01/2026.
- Preferred Drug and Prior Authorization Program — Prior Authorization (PA) Criteria Instructions — Alabama Medicaid Agency, Division of Pharmacy Services. Printed in the footer of every page; the only effective date on the paper: Effective 07/01/2026.
Nothing on this page is medical advice, and nobody here is a clinician. Coverage rules change; check the linked document before you rely on it.
If you're paying cash instead
These providers list Alabama in their service area. Partners appear first. These are medication prices, not confirmed monthly totals. Other fees may apply; check each provider’s terms before choosing.
Some providers pay us a commission when you sign up through our links, at no extra cost to you.
| Provider | Monthly price and terms | Go to the provider |
|---|---|---|
Gala HealthCCaveat | $1,299 a month, medication only brand Ozempic (semaglutide), cash price Brand-name Ozempic, quoted as a cash price. Gala says insurance may reduce it and does not publish what it would reduce it to. Additional fees not verified. Price details
| View pricing at Gala Health (opens in a new tab)Partner |
TeleClinicAVerified | $79 a month, medication only compounded semaglutide Billed monthly, same price at every vial strength, and the product page says the rate is locked for the life of the membership. Additional fees not verified. Price details
| View pricing at TeleClinic (opens in a new tab) |
TelePeptideAVerified | $229 a month, medication only compounded semaglutide Dissolvable tablet, month-to-month. TelePeptide states on the same page that it does not sell branded GLP-1s. Additional fees not verified. Price details
| View pricing at TelePeptide (opens in a new tab) |
Care Bare RxBMinor gap | $199 a month, medication only compounded tirzepatide Both compounded drugs are quoted at the same starting figure, on one line that also puts brand names on them. Additional fees not verified. Price details
| View pricing at Care Bare Rx (opens in a new tab) |
Peak WellnessBMinor gap | $249 a month, medication only compounded semaglutide $179 covers the first month only, and the page says so on the same line. Prepaying drops it: $597 once for three months, which is $199 a month, or $990 once for six, which is $165 — but a prepaid plan is not refundable. The price is the same at every dose. Additional fees not verified. Price details
| View pricing at Peak Wellness (opens in a new tab) |
Rx.comBMinor gap | $175 a month, medication only compounded semaglutide One month, all-in: the visit, the medication at any dose, supplies and cold shipping. The $146 headline is the six-month plan, paid as $875 in one payment. Additional fees not verified. Price details
| View pricing at Rx.com (opens in a new tab) |
TrimiBMinor gap | $175 a month, medication only compounded semaglutide, billed monthly Month to month. $99 is the twelve-month rate, billed $1,188 upfront, and it's the only semaglutide figure on the homepage. Medication, supplies, provider access and shipping included. Monthly renewal is automatic; payment precedes provider review. Additional fees not verified. Price details
| View pricing at Trimi (opens in a new tab) |
MojoonCCaveat | $390 a month, medication only compounded tirzepatide Advertised at $1,000. The bottom of a $390–$490 range. Unlike the semaglutide page, this one never says what moves the price across that range. Additional fees not verified. Price details
| View pricing at Mojoon (opens in a new tab) |
Our grading method and how we verify a price explain what those letters mean and where these figures came from.